文献速递口腔修复与种植牙周病

免疫抑制肾移植患者种植治疗的前瞻性病例对照研究

Implant treatment in immunosuppressed renal transplant patients: A prospective case-controlled study.
PubMed 文献 · Clin Oral Implants Res · 2019-04-29

本研究前瞻性评估免疫抑制肾移植患者种植治疗的长期结局,并与匹配对照组比较,平均随访116.8个月。结果显示两组种植体存活率均超过98%,种植体周围黏膜炎和种植体周围炎发生率组间无显著差异,伤口愈合与术后疼痛相似。结论认为药理性免疫抑制未影响种植体结局,但肾移植患者种植后需定期监测维护。

要点

  • 免疫抑制肾移植患者种植体存活率超过98%,与对照组相当。
  • 种植体周围黏膜炎和种植体周围炎发生率组间无明显差异。
  • 肾移植患者种植后应定期监测和维持口腔及全身健康。

核心结论

  • 药理性免疫抑制未影响肾移植患者的种植体结局。
  • 肾移植患者种植治疗后应仔细定期控制随访。

研究设计与样本

  • 前瞻性病例对照研究,纳入2001至2011年接受种植治疗的药理性免疫抑制肾移植患者,并设匹配非移植对照组。
  • 平均随访116.8个月(范围84至192个月),前瞻性测量牙周、临床和影像学参数。

主要发现

  • 种植体存活率研究组为100%,对照组为98.84%,两组均超过98%。
  • 种植体周围黏膜炎研究组累及46.80%的种植体,对照组为48.80%。
  • 种植体周围炎研究组累及5.10%的种植体,对照组为8.10%。
  • 两组伤口愈合和术后疼痛相似。

临床怎么用

  • 免疫抑制肾移植患者可在必要的长期监测和定期维护下接受牙种植治疗。
  • 种植后应定期监测口腔及全身健康状况。

局限性

  • 原文提及本研究存在局限性,但未具体说明局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The aim of this clinical study was to evaluate long-term outcomes of implant therapy in a cohort of immunosuppressed renal transplant patients compared with a matched control group. MATERIAL AND METHODS: Pharmacologically immunosuppressed renal transplant patients received dental implant treatment between 2001 and 2011. Periodontal, clinical and radiographic parameters were prospectively measured with a mean follow-up of 116.8 months (range from 84 to 192 months). A matched controlled non-transplant sample receiving similar implant treatment in the same time was included as a control group. RESULTS: Implant survival rate was over 98% in both test and control groups (100% and 98.84%, respectively). Peri-implant mucositis was diagnosed in 46.80% of the implants in the study group and in 48.80% in the control group. Peri-implantitis occurred in 5.10% of the implants in the study group and in 8.10% of the controls. Wound healing and post-operative pain were similar in both groups. CONCLUSIONS: Despite the limitations of this study, pharmacological immunosuppression in renal transplant patients did not affect implant outcomes. Renal transplant patients should be carefully controlled periodically after implant treatment. CLINICAL IMPLICATIONS: The results from this investigation justify the use of dental implants for the dentalrehabilitation of immunosuppressed patients after renal transplantation provided they follow the necessarylong-term monitoring and regular maintenance of their oral and systemic health.

来源:Clin Oral Implants Res,查看原文。版权归原作者所有。

引用

  1. Hernández G, Paredes V, López-Pintor RM, et al. Implant treatment in immunosuppressed renal transplant patients: A prospective case-controlled study. Clin Oral Implants Res. 2019. PMID: 30980770. doi:10.1111/clr.13437

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。